Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital

Journal of Infection and Public Health

Volumn 6, Issue 3, 2013, Pages 179-185

  De Francesco, M A ^a   Ravizzola, G ^a   Peroni, L ^a   Bonfanti, C ^a   Manca, N ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

A. baumannii; Antibiotic resistance; Antibiotics; Infection; P. aeruginosa

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; RETROSPECTIVE STUDY; SKIN; SOFT TISSUE; URINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-INFECTIVE AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 84877664847     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2012.11.006     Document Type: Article

References (24)

1. Geffers C., Sohr D., Gastmeier P. Mortality attributable to hospital-acquired infections among surgical patients. Infection Control and Hospital Epidemiology 2008, 229:1167-1170.
2. Aranaz-Andres J.M., Albar- Remon C., Vitaller-Murillo J., Ruiz-Lòpez P., Limon-Ramìrez R., Terol-Garcia E., et al. Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events. Journal of Epidemiology and Community Health 2008, 62:1022-1029.
3. Pittet D., Tarara D., Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271:1598-1601.
4. Beyersmann J., Gastmeier P., Grundmann H., Bärwolff S., Geffers C., Behnke M., et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infection Control and Hospital Epidemiology 2006, 27:493-499.
5. Bonten M.J. Healthcare epidemiology: ventilator-associated pneumonia-preventing the inevitable. Clinical Infectious Diseases 2011, 52:115-121.
6. Boucher H.W., Talbot G.H., Bradley J.S., Edwards J.E., Gilbert D., Rice L.B., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical Infectious Diseases 2009, 48:1-12.
7. Morgan D.J., Weisenberg S.A., Augenbraun M.H., Calfee D.P., Currie B.P., Furuya E.Y., et al. Multi-drug resistant Acinetobacter baumannii in New York City-10 years into the epidemic. Infection Control and Hospital Epidemiology 2009, 30:196-197.
8. Pournaras S., Markogiannakis A., Ikonomidis A., Kondyli L., Bethimouti K., Maniatis A.N., et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. Journal of Antimicrobial Chemotherapy 2006, 57:557-561.
9. Livermore D.M., Hill R.L., Thomson H., Charlett A., Turton J.F., Pike R., et al. Antimicrobial treatment and clinical outcome for infections with carbapenem and multiply-resistant Acinetobacter baumannii around London. International Journal of Antimicrobial Agents 2010, 35:19-24.
10. Peleg A., Seifert H., Paterson D.L. Acinetobacter baumannnii: emergence of a successful pathogen. Clinical Microbiology Reviews 2008, 21:528-582.
11. Ying C.M., Ling T.K., Lee C.C., Ling J.M. Characterization of carbapenem-sensitive and-resistant Acinetobacter baumannii in Shangai and Hong Kong. Journal of Medical Microbiology 2006, 55:799-802.
12. Walkty A., Decorby M., Nichol K., Mulvey M.R., Hoban D., Zhanel G., et al. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian National Intensive Care Unit study. Diagnostic Microbiology and Infectious Disease 2008, 61:217-221.
13. Scheffer M.C., Bazzo M.L., Steindel M., Darini A.L., Climaco E., Dalla-Costa L.M. Intrahospital spread of carbapenem-resistant Pseudomonas aeruginosa in a University Hospital in Florianopolis, Santa Catarina, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 2010, 43:367-371.
14. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing. M100-S20 M-2 and M-7, Wayne, PA; 2010.
15. Falagas M.E., Kasiakou S.K. Colistin: the re-emerging antibiotic for multi-drug resistant Gram-negative bacterial infections. Clinical Infectious Diseases 2005, 40:1333-1341.
16. McCracken M., DeCorby M., Fuller J., Loo V., Hoban D.J., Zhanel G.G., et al. Identification of multi-drug and carbapenem-resistant Acinetobacter baumannii in Canada: results from the CANWARD 2007. Journal of Antimicrobial Chemotherapy 2009, 64:552-555.
17. Chaster J. Infections due to Acinetobacter baumannii in the ICU. Seminars in Respiratory and Critical Care Medicine 2003, 24:69-78.
18. Peleg A.Y., Hooper D.C. Hospital-acquired infections due to gram-negative bacteria. New England Journal of Medicine 2010, 362:1804-1813.
19. Clark N.M., Patterson J., Lynch J.P. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Current Opinion in Critical Care 2003, 9:413-423.
20. Mahgoub S., Ahmed J., Glatt A.E. Completely resistant Acinetobacter baumannii strains. Infection Control and Hospital Epidemiology 2002, 23:477-479.
21. Lee K., Lee M.A., Lee C.H., Lee J., Roh K.H., Kim S., et al. Increase of ceftazidime and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007. Yonsei Medical Journal 2010, 51:901-911.
22. Mera R.M., Miller L.A., Amrine-Madsen H., Sahm D.F. Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States. Microbial Drug Resistance 2010, 16:209-215.
23. Brusselaers, Monstrey S., Snoeij T., Vandijck D., Lizy C., Hoste E., et al. Morbidity and mortality of bloodstream infections in patients with severe burn injury. American Journal of Critical Care 2010, 19:81-87.
24. Falagas M.E., Fragoulis K.N., Kasiakou S.K., Sermaidis G.J., Michalopoulos A. Nephrotoxicity of intravenous colistin: a prospective evaluation. International Journal of Antimicrobial Agents 2005, 26:504-507.